GlassScriptPhysician profile
Ryan Christopher Wolbach
NPI 1881384485
$651.02
in general payments reported to CMS, 2019-2025
12 companies · $155 in 2025
The $155 reported for 2025 was less than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $311 · 2024: $185 · 2025: $155.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $651.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $651.02 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $153.13 | 2023-2025 | Airsupra, Farxiga |
| Novo Nordisk INC | $89.81 | 2023-2024 | Ozempic, Rybelsus, Wegovy |
| Viiv Healthcare Company | $72.64 | 2023-2024 | Apretude |
| Teva Pharmaceuticals USA, INC. | $61.96 | 2023-2024 | Ajovy |
| Lilly USA, LLC | $55.08 | 2023 | Mounjaro, Trulicity |
| Abbvie INC. | $48.93 | 2023-2025 | |
| Pfizer INC. | $47.49 | 2023-2024 | |
| Esperion Therapeutics, INC. | $29.79 | 2023 | Nexletol |
| Harmony Biosciences LLC | $29.44 | 2024 | |
| Exact Sciences Corporation | $27.64 | 2024 | Cologuard Collection Kit |
| Novartis Pharmaceuticals Corporation | $21.52 | 2023 | |
| Idorsia Pharmaceuticals US INC | $13.59 | 2023 | Quviviq |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ryan Wolbach listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.